AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
2004 SEP 2 - (NewsRx.com & NewsRx.net) -- PURE Bioscience (OTCBB:PURE) announced that it has retained the law firm of McDermott Will & Emery to fortify the intellectual property protection of its silver dihydrogen citrate technology.
Firm Partner Cathryn Campbell, PhD, will focus on PURE's silver dihydrogen citrate pharmaceutical Patent Portfolio. Campbell serves as cochair of the firm's Life Sciences Group and is also head of the firm's San Diego Intellectual Property and Life Sciences IP practices.
Campbell, who has been practicing in the areas of biotechnology intellectual property more than 23 years, concentrates her practice on biotechnology patent law and has extensive experience in developing patent portfolio strategies, negotiating and drafting license agreements and preparing patentability, validity, infringement and freedom to operate opinions. She represents biotechnology and pharmaceutical companies, as well as numerous non-profit universities and institutions.
Campbell has been recognized by California Lawyer as one of the state's top patent lawyers.
McDermott Will & Emery is a premier international law firm with a diversified business practice. Numbering more than 1000 lawyers, McDermott Will & Emery has offices in Boston, Brussels, Chicago, Dusseldorf, London, Los Angeles, Miami, Milan, Munich, New York, Orange County, Rome, San Diego, Silicon Valley and Washington, D.C.
The firm's Intellectual Property (IP) Department includes more than 160 lawyers and patent agents working in all of its offices throughout the world. McDermott Will & Emery is renowned for its IP trial and appellate experience, and it is ranked as one of the strongest IP litigation firms for both plaintiffs and defendants.
PURE Bioscience's antimicrobial technologies lead today's global trend toward industry and consumer use of "green" products while providing competitive advantages in efficacy and safety. This new molecule, silver dihydrogen citrate (SDC), is an electrolytically generated ...
Source: HighBeam Research, Bioscience company retains McDermott Will & Emery.